CN112184259A - Drug supervision early warning system and method - Google Patents
Drug supervision early warning system and method Download PDFInfo
- Publication number
- CN112184259A CN112184259A CN202010995358.8A CN202010995358A CN112184259A CN 112184259 A CN112184259 A CN 112184259A CN 202010995358 A CN202010995358 A CN 202010995358A CN 112184259 A CN112184259 A CN 112184259A
- Authority
- CN
- China
- Prior art keywords
- drug
- medicine
- unit
- minimum
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 508
- 229940079593 drug Drugs 0.000 title claims abstract description 310
- 238000000034 method Methods 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 claims abstract description 39
- 238000004458 analytical method Methods 0.000 claims abstract description 19
- 238000007405 data analysis Methods 0.000 claims abstract description 11
- 238000013500 data storage Methods 0.000 claims abstract description 11
- 238000003860 storage Methods 0.000 claims description 22
- 238000012795 verification Methods 0.000 claims description 16
- 238000013480 data collection Methods 0.000 claims description 10
- 238000009826 distribution Methods 0.000 claims description 10
- 238000012544 monitoring process Methods 0.000 claims description 8
- 238000001647 drug administration Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 13
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000013475 authorization Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000003962 counterfeit drug Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/018—Certifying business or products
- G06Q30/0185—Product, service or business identity fraud
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
- G06F16/27—Replication, distribution or synchronisation of data between databases or within a distributed database system; Distributed database system architectures therefor
Abstract
The embodiment of the invention discloses a drug supervision early warning system and a drug supervision early warning method. The system comprises: the system comprises a medicine data acquisition unit, a medicine data storage unit and a medicine data analysis unit; the drug data acquisition unit is configured to acquire drug tracing data reported by the drug minimum sale unit when the drugs are circulated in each drug circulation link; wherein the medicine circulation link comprises: a drug production link, a drug circulation link and a drug sales link; the drug data storage unit is configured to link and store drug tracing data of the drug minimum sale unit in each drug circulation link; the drug data analysis unit is configured to perform early warning analysis on the drug minimum sales unit according to the drug tracing data associated with the drug minimum sales unit. The medicine tracing information intercommunication sharing and the whole variety and whole process tracing are realized, the medicine quality safety comprehensive treatment can be effectively promoted, and the medicine quality safety guarantee level is improved.
Description
Technical Field
The embodiment of the invention relates to the field of medicine safety, in particular to a medicine supervision early warning system and a medicine supervision early warning method.
Background
In recent years, the problems of counterfeit and inferior medicines always puzzles consumers and causes great hidden danger to the life safety of the consumers. For example, consumers are often concerned about whether a drug is genuine or whether the drug is of acceptable quality when purchasing the drug. However, in the above case, the consumer can only verify whether the retail store or the medical institution selling the medicine is authorized, thereby verifying the quality of the medicine. However, a lawbreaker may cause counterfeit drugs to appear in a regular medical institution or a drug retail store through an illegal channel, and thus may buy the counterfeit drugs even in the regular medical institution. Therefore, how to effectively supervise and early warn the produced medicines becomes important.
Disclosure of Invention
The embodiment of the invention provides a drug supervision early warning system and a drug supervision early warning method, which are used for tracing the whole process of produced drugs and effectively supervising and early warning the quality of the drugs.
In a first aspect, an embodiment of the present invention provides a supervision and early warning system, where the system includes a drug data acquisition unit, a drug data storage unit, and a drug data analysis unit; wherein the content of the first and second substances,
the drug data acquisition unit is configured to acquire drug tracing data reported by the drug minimum sale unit when each drug circulation link circulates; wherein, the medicine circulation link comprises: a drug production link, a drug circulation link and a drug sales link;
the drug data storage unit is configured to link and store drug tracing data of the drug minimum sale unit in each drug circulation link;
the drug data analysis unit is configured to perform early warning analysis on the drug minimum sales unit according to the drug tracing data associated with the drug minimum sales unit.
In a second aspect, an embodiment of the present invention further provides a method for monitoring and warning a drug, where the method includes:
collecting drug tracing data reported by a drug minimum sale unit when each drug circulation link carries out circulation; wherein, the medicine circulation link comprises: a drug production link, a drug circulation link and a drug sales link;
linking and storing the drug tracing data of the drug minimum sale unit in each drug circulation link;
and carrying out early warning analysis on the minimum medicine sale unit according to the medicine tracing data associated with the minimum medicine sale unit.
The embodiment of the invention provides a drug supervision and early warning system, which is characterized in that drug data acquisition is realized by acquiring drug tracing data reported by a drug minimum sale unit during circulation in a drug production link, a drug circulation link and a drug sale link, then the drug tracing data of the drug minimum sale unit in the drug circulation link is linked and stored to realize drug data storage, and then early warning analysis is performed on the drug minimum sale unit according to the drug tracing data associated with the drug minimum sale unit to realize supervision and early warning analysis of drug circulation conditions.
By adopting the technical scheme, the medicine tracing data reported by the minimum medicine sale unit in each medicine circulation link can be collected and stored in a link mode, the intercommunication and sharing of medicine tracing information are strengthened, the whole variety and whole process tracing are realized, a supervision department can timely and comprehensively know the production, operation and use conditions of medicines, the medicine source can be checked, the medicine source can be traced, the responsibility can be studied, the medicine decision can be made by the supervision department in an auxiliary mode, early warning analysis is carried out according to the medicine tracing data, the comprehensive treatment of medicine quality safety is effectively promoted, and the medicine quality safety guarantee level is improved.
The above summary of the present invention is merely an overview of the technical solutions of the present invention, and the present invention can be implemented in accordance with the content of the description in order to make the technical means of the present invention more clearly understood, and the above and other objects, features, and advantages of the present invention will be more clearly understood.
Drawings
Other features, objects and advantages of the invention will become more apparent upon reading of the following detailed description of non-limiting embodiments thereof, made with reference to the accompanying drawings. The drawings are only for purposes of illustrating the preferred embodiments and are not to be construed as limiting the invention. Also, like reference numerals are used to refer to like parts throughout the drawings. In the drawings:
fig. 1 is a block diagram of a drug supervision early warning system provided in an embodiment of the present invention;
FIG. 2 is a schematic diagram of an architecture of a drug administration system provided in an embodiment of the present invention;
fig. 3 is a flow chart of a drug traceability data acquisition scheme provided in an embodiment of the present invention;
FIG. 4 is a flowchart of a method for monitoring and warning drugs according to an embodiment of the present invention;
Detailed Description
The present invention will be described in further detail with reference to the accompanying drawings and examples. It is to be understood that the specific embodiments described herein are merely illustrative of the invention and are not limiting of the invention. It should be further noted that, for the convenience of description, only some of the structures related to the present invention are shown in the drawings, not all of the structures.
Before discussing exemplary embodiments in more detail, it should be noted that some exemplary embodiments are described as processes or methods depicted as flowcharts. Although a flowchart may describe the operations (or steps) as a sequential process, many of the operations can be performed in parallel, concurrently or simultaneously. In addition, the order of the operations may be re-arranged. The process may be terminated when its operations are completed, but may have additional steps not included in the figure. The processes may correspond to methods, functions, procedures, subroutines, and the like.
The drug supervision early warning system and method provided in the embodiments of the present invention are explained in detail through the embodiments and the alternatives of the embodiments.
Example one
Fig. 1 is a block diagram of a medicine supervision and early warning system provided in an embodiment of the present invention, and the technical solution of this embodiment is applicable to the case of supervision and early warning of medicine information and medicine data, especially to the case of tracing, monitoring and early warning of medicine data of all varieties and all processes. As shown in fig. 1, the drug administration early warning system provided in the embodiment of the present invention may include: a drug data collection unit 110, a drug data storage unit 120, and a drug data analysis unit 130. Wherein:
the drug data collection unit 110 is configured to collect drug tracing data reported by the drug minimum sales unit during the circulation of each drug circulation link; wherein, the medicine circulation link comprises: a medicine production link, a medicine circulation link and a medicine sale link.
The drug data storage unit 120 is configured to link and store drug tracing data of the drug minimum sales unit in each drug circulation link.
The drug data analysis unit 130 is configured to perform early warning analysis on the minimum drug sale unit according to the drug tracing data associated with the minimum drug sale unit.
In this embodiment, fig. 2 is a schematic structural diagram of a drug administration system provided in an embodiment of the present invention. Referring to fig. 2, the drug tracing data collection in the drug supervision and early warning system is realized through a drug tracing collaborative platform, drug tracing data reported when a producer, a distributor, a logistics enterprise, a medical institution and a retailer are circulated are collected and stored on the drug tracing collaborative platform to form a chain drug tracing information base, all chain drug flow direction data tracing data of drug production, circulation, a sales enterprise, an end user and the like are gathered through data collection, enterprise authorization acquisition and the like, and analysis and early warning of the drug tracing data are completed through an early warning analysis subsystem shown in the figure.
In this embodiment, referring to fig. 2, after the data center analyzes and decides the drug tracing data, the drug supervision and early warning system can be connected with an external government system and an external drug system, and can realize information interaction with a drug administration and the public through electronic communication equipment.
In this embodiment, when data acquisition is performed on the minimum sales unit of a drug, the drug tracing data that needs to be acquired includes: the method comprises the steps that the inlet and outlet receipt information of any minimum drug selling unit in a corresponding drug circulation link and the unique tracing identifier (drug tracing code information) of the minimum drug selling unit determined by a manufacturer can comprise the unique tracing identifier on the minimum drug selling unit and the identifier incidence relation between the unique tracing identifiers arranged on each level of outer package of the minimum drug selling unit.
Specifically, alternatively, the medication minimum sales unit may be a bag, a box, a bottle, a sheet, a plate (capsule), or the like, and the outer packages of the stages of the medication minimum sales unit may be a bag, a box, or the like. The unique medicine tracing identifier (medicine tracing code information) can be an identifier pasted or printed by manufacturers such as production information, a bar code and a two-dimensional code on the minimum medicine selling unit, and can also be information pasted or printed on each level of outer packages of the minimum medicine selling unit, the bar code, the two-dimensional code and the like.
In this embodiment, optionally, the medicine data acquisition unit is connected to scanning devices arranged in different circulation links in the market medicine tracing system, and the scanning devices are configured to scan and obtain the tracing code information of the minimum medicine sales unit to obtain the medicine tracing data. Therefore, the medicine supervision and early warning system can timely acquire the circulation condition of the traceback code information of the minimum sales unit of each medicine in each circulation link by means of scanning equipment which is pre-deployed in each circulation link.
In this embodiment, the drug data collection unit may further be optionally connected to a third-party data platform, and the third-party data platform is configured to provide drug tracing data of the drug minimum sales unit in at least part of the circulation link. Therefore, the drug supervision and early warning system can assist in obtaining the circulation condition of the traceback code information of the minimum sales unit of each drug in at least part of circulation links by means of a third party, and does not need to spend more cost on deploying scanning equipment in each circulation link and save the cost of maintaining equipment.
Specifically, the scanning devices disposed in different scanning links may include: electronic equipment scanned by a manufacturer in a warehouse, electronic equipment scanned by each dealer in a warehouse in a circulation link, and scanning equipment used by retailers in a sale link. Of course, the electronic devices may be various electronic devices having communication, scanning, and storage functions, and specific models thereof are not limited herein, and only corresponding functions are required.
In this embodiment, the storage of the drug data storage unit is completed on the drug tracing collaboration platform, specifically, a block chain technology is adopted, the drug tracing data of the drug minimum sales unit in each drug circulation link is subjected to uplink storage, and the drug tracing data of the drug minimum sales unit which belongs to the same uplink storage is integrated.
In this embodiment, optionally, when analyzing the drug data, specifically, when a consumer scans a minimum sales unit of a drug, the drug supervision and early warning system queries the drug tracing data associated with the scanned minimum sales unit of the drug; and determining whether the current medicine flow direction of the scanned medicine minimum selling unit is consistent with the medicine flow direction indicated by the pre-stored medicine tracing data or not, so as to determine whether to trigger the early warning of the serial goods of the scanned medicine minimum selling unit or not.
Specifically, a consumer scans a minimum sales unit of the medicine, and mobile electronic devices which can be connected with the internet, such as a mobile phone and a tablet computer, are used. The method comprises the steps that when actual medicine flow direction, medicine distribution and medicine circulation information of a scanned medicine minimum selling unit are inconsistent with corresponding tracing code information of a block chain library, serial-product early warning is triggered to be carried out on the scanned medicine minimum selling unit.
In this embodiment, optionally, the drug supervision and early warning system may further analyze drug flow direction distribution of the similar drugs based on drug tracing data associated with each drug minimum sales unit, so as to obtain inventory distribution and warehouse-in and warehouse-out distribution conditions of the similar drugs in different jurisdictions. Therefore, various types of medicines in all jurisdictions can be supplemented in time, shortage of medicine supply is avoided, and medicine supply is effectively guaranteed.
In this embodiment, optionally, the drug supervision and early warning system performs early warning analysis on each drug minimum sale unit according to a preset drug early warning rule, so as to recall the drug minimum sale unit meeting the early warning rule; wherein the early warning rules may include at least one of: production license expiration warning, GMP certificate expiration warning, operation license certificate expiration warning, GSP certificate expiration warning, approved document number expiration warning and drug expiration warning. Of course, the method can also comprise suspicious drug early warning, drug return early warning, drug adverse reaction early warning and the like.
In this embodiment, in an optional example, the enterprise qualification certificate list may be queried according to the name of the enterprise, the certificate type, the certificate number, and the like, and which qualification certificates of the enterprise are about to expire or have expired. In another alternative example, the list of drugs may be queried by drug type, specification, lot number, manufacturer, and approved document number, listing the expiration time of the drug information and approved document number, and looking up which approved documents will expire or have expired in chronological order. In yet another alternative example, the list of drugs may be queried according to the drug type, specification, production lot number, manufacturing enterprise, and approval document number, and the information of the drugs, the production date of the drugs, and the expiration date of the validity period may be listed, and sorted according to the date, so as to facilitate checking which drugs are about to expire or have expired.
The technical scheme of the embodiment collects the drug tracing data reported when circulating among manufacturers, distributors, logistics enterprises, medical institutions and retailers, stores the drug tracing data in a drug tracing collaborative platform to form a chain drug tracing information base, provides intelligent analysis decision support, pre-risk early warning and post-analysis for supervision departments through the big data technology of the early warning analysis subsystem of the drug supervision early warning system, solves the problems of insufficient hands and relatively lagged supervision means of the current drug supervision departments, achieves the aims of realizing information and intelligent supervision of the whole process of drugs, perfecting a risk early warning mechanism, fully exerts the functions of the drug tracing data in problem product recall and emergency treatment work, and can further mine the application value of the drug tracing data in supervision inspection, product sampling inspection and daily supervision, the technical effects of effectively promoting the comprehensive treatment of the drug quality safety and improving the drug quality safety guarantee level are realized.
Example two
Fig. 3 is a flow chart of a drug traceability data acquisition scheme provided in an embodiment of the present invention. Referring to fig. 3, in the embodiment, information intercommunication sharing and synchronization are realized by collecting the drug tracing data of the minimum drug selling unit in three circulation links, namely a drug production link, a drug circulation link and a drug selling link, and the full-chain drug flow direction data tracing data of drug production, circulation, sales enterprises, end users and the like are gathered. The acquired medicine tracing data of each link are collected and then are uploaded and stored to the medicine tracing comprehensive platform in a unified way, so that the medicine supervision department can analyze the collected data, the obtained tracing result can be used for inquiring, early warning and checking, and public consumers can also perform medicine authentication and medicine effect feedback on the purchased medicines.
In one alternative of this embodiment, this embodiment may be combined with each of the alternatives of one or more of the embodiments described above. In the drug tracing data acquisition scheme of this embodiment, optionally, when it is detected that a drug production link of the minimum drug selling unit is ex-warehouse, the ex-warehouse receipt information and the drug tracing code information of the minimum drug selling unit in the drug production link are acquired to serve as drug tracing data when drugs of the minimum drug selling unit are circulated in the drug production link.
In another alternative of this embodiment, this embodiment may be combined with each of the alternatives of one or more of the embodiments described above. In the medicine tracing data acquisition scheme of the embodiment, optionally, when detecting that the minimum medicine sales unit is put in storage in the medicine circulation link, consistency verification is performed on corresponding tracing code information and delivery receipt information provided in the medicine production link and corresponding delivery receipt information acquired in the medicine production link;
and under the condition of passing the verification, acquiring the delivery receipt and the drug tracing code information of the drug minimum sale unit in the drug circulation link, so as to be used as drug tracing data of the drug minimum sale unit when the drug is circulated in the drug circulation link.
In yet another alternative of this embodiment, this embodiment may be combined with each of the alternatives of one or more of the embodiments described above. In the medicine tracing data acquisition scheme of the embodiment, optionally, when detecting that the minimum medicine sales unit enters the warehouse in the medicine sales link, consistency verification is performed on corresponding tracing code information and warehouse-out document information provided in the medicine circulation link and corresponding warehouse-out document information acquired in the medicine circulation link;
and under the condition of passing the verification, acquiring the ex-warehouse receipt and the medicine tracing code information of the minimum medicine selling unit in the medicine selling link to serve as medicine tracing data of the minimum medicine selling unit when the medicine is circulated in the medicine selling link.
In the three alternatives, the warehouse-out receipt information and the medicine tracing code information of the medicine production link are collected firstly, then the corresponding tracing code information and the warehouse-out receipt information provided by the medicine production link are subjected to consistency verification with the corresponding warehouse-out receipt information collected in the medicine production link when the medicine circulation link is put in storage, the warehouse-out receipt and the medicine tracing code information collected in the medicine circulation link after the verification is passed are used as the medicine tracing data of the medicine of the minimum sales unit during circulation in the medicine circulation link, finally the corresponding tracing code information and the warehouse-out receipt information provided by the medicine circulation link are subjected to consistency verification with the corresponding warehouse-out receipt information collected in the medicine circulation link when the medicine is put in storage in the medicine sales link, and the warehouse-out receipt and the medicine tracing code information of the minimum sales unit during the medicine sales link are collected after the verification is passed, the method is used as medicine tracing data of the medicine in the minimum selling unit of the medicine during circulation in the medicine selling link.
According to the technical scheme, through the modes of data acquisition or enterprise authorization acquisition and the like, the full-chain drug flow direction data tracing data of drug production, circulation, sales enterprises, end users and the like are gathered, the problems that the existing drug data are dispersed in production enterprises, circulation enterprises, retail and medical institutions, drug administration and any enterprise platform do not have full-chain tracing data, and drug tracing is difficult are solved, the effect of strengthening drug tracing information intercommunication sharing is achieved, and the effect of tracing the full varieties and the whole process of drug data information is realized.
EXAMPLE III
Fig. 4 is a flowchart of a method for monitoring and warning a drug in an embodiment of the present invention. The embodiment of the application is suitable for drug data information tracing and monitoring of a drug supervision and early warning system and early warning, especially for drug data tracing, monitoring and early warning of all varieties and all processes. As shown in fig. 4, the method for monitoring and warning a drug in an embodiment of the present invention may include the following steps:
and S410, collecting the drug tracing data reported by the drug minimum sale unit in the process of transferring in each drug transferring link.
On the basis of the above embodiment, specifically, the drug circulation link includes:
a medicine production link, a medicine circulation link and a medicine sale link.
On the basis of the above embodiment, specifically, the medicine tracing data includes the delivery receipt information and the medicine tracing code information in the corresponding medicine circulation link.
On the basis of the above embodiment, specifically, the medicine tracing back code information includes a unique tracing back identifier of the medicine minimum sales unit and an identifier association relationship between the unique tracing back identifiers set on the outer packages of the respective stages of the medicine minimum sales unit.
On the basis of the above embodiment, specifically, collecting the drug tracing data reported by the drug minimum sales unit during the transfer in each drug transfer link includes:
when the drug production link of the drug minimum sale unit is detected to be ex-warehouse, the out-warehouse receipt information and the drug tracing code information of the drug minimum sale unit in the drug production link are collected to be used as drug tracing data when the drugs of the drug minimum sale unit are circulated in the drug production link.
The medicine tracing data that reports when gathering the minimum unit of selling of medicine when each medicine circulation link circulates still includes:
when detecting that the minimum medicine sales unit is put in storage in the medicine circulation link, carrying out consistency verification on corresponding tracing code information and ex-storage document information provided in the medicine production link and corresponding ex-storage document information collected in the medicine production link;
and under the condition of passing the verification, acquiring the delivery receipt and the drug tracing code information of the drug minimum sale unit in the drug circulation link, so as to be used as drug tracing data of the drug minimum sale unit when the drug is circulated in the drug circulation link.
The medicine tracing data that reports when gathering the minimum unit of selling of medicine when each medicine circulation link circulates still includes:
when the minimum medicine sales unit is detected to be put in storage in the medicine sales link, consistency verification is carried out on corresponding tracing code information and ex-storage document information provided in the medicine circulation link and corresponding ex-storage document information collected in the medicine circulation link;
and under the condition of passing the verification, acquiring the ex-warehouse receipt and the medicine tracing code information of the minimum medicine selling unit in the medicine selling link to serve as medicine tracing data of the minimum medicine selling unit when the medicine is circulated in the medicine selling link.
On the basis of the above embodiment, specifically, the medicine data acquisition unit is connected with scanning devices arranged in different circulation links, and the scanning devices are used for scanning and acquiring the tracing code information of the minimum medicine sales unit to obtain medicine tracing data.
On the basis of the above embodiment, specifically, the drug data acquisition unit is connected to a third-party data platform, and the third-party data platform is used for providing drug traceability data of the drug minimum sales unit in at least part of the circulation links.
And S420, linking and storing the medicine tracing data of the minimum medicine sale unit in each medicine circulation link.
On the basis of the above embodiment, specifically, the link storage of the minimum drug sales unit in the drug tracing data of each drug circulation link includes:
and adopting a block chain technology to carry out uplink storage on the medicine tracing data of the minimum medicine sale unit in each medicine circulation link, and integrating the uplink stored medicine tracing data of each minimum medicine sale unit which belongs to the same medicine.
And S430, performing early warning analysis on the minimum medicine sale unit according to the medicine tracing data associated with the minimum medicine sale unit.
On the basis of the above embodiment, specifically, the performing an early warning analysis on the minimum sales unit of the drug includes:
when a consumer scans a minimum drug sale unit, drug tracing data related to the scanned minimum drug sale unit is inquired;
and determining whether the current medicine flow direction of the scanned medicine minimum selling unit is consistent with the medicine flow direction indicated by the pre-stored medicine tracing data or not, so as to determine whether to trigger the early warning of the serial goods of the scanned medicine minimum selling unit or not.
And analyzing the medicine flow direction distribution of the similar medicines based on the medicine tracing data associated with the minimum medicine sale units to obtain the inventory distribution and warehouse-in and warehouse-out distribution conditions of the similar medicines in different jurisdictions.
According to preset medicine early warning rules, early warning analysis is carried out on each medicine minimum sale unit, so that medicine recalling is carried out on the medicine minimum sale units which accord with the early warning rules;
wherein the early warning rules include at least one of: production license expiration warning, GMP certificate expiration warning, operation license certificate expiration warning, GSP certificate expiration warning, approved document number expiration warning and drug expiration warning.
The drug supervision and early warning method provided by the embodiment of the invention can be applied to the drug supervision and early warning system provided by any embodiment of the invention, has corresponding functions and beneficial effects of the drug supervision and early warning system for executing the drug supervision and early warning method, and the technical details not described in detail in the embodiment can be referred to the operation process of the drug supervision and early warning system provided by any embodiment of the application.
In the description herein, references to the description of the term "one embodiment," "some embodiments," "an example," "a specific example," or "some examples," etc., mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
It is to be noted that the foregoing is only illustrative of the preferred embodiments of the present invention and the technical principles employed. It will be understood by those skilled in the art that the present invention is not limited to the particular embodiments described herein, but is capable of various obvious changes, rearrangements and substitutions as will now become apparent to those skilled in the art without departing from the scope of the invention. Therefore, although the present invention has been described in greater detail by the above embodiments, the present invention is not limited to the above embodiments, and may include other equivalent embodiments without departing from the spirit of the present invention, and the scope of the present invention is determined by the scope of the appended claims.
Claims (13)
1. A drug administration pre-warning system, the system comprising: the system comprises a medicine data acquisition unit, a medicine data storage unit and a medicine data analysis unit; wherein the content of the first and second substances,
the drug data acquisition unit is configured to acquire drug tracing data reported by the drug minimum sale unit when each drug circulation link circulates; wherein, the medicine circulation link comprises: a drug production link, a drug circulation link and a drug sales link;
the drug data storage unit is configured to link and store drug tracing data of the drug minimum sale unit in each drug circulation link;
the drug data analysis unit is configured to perform early warning analysis on the drug minimum sales unit according to the drug tracing data associated with the drug minimum sales unit.
2. The system of claim 1, wherein the drug traceability data comprises export documentation information and drug traceability code information for a corresponding drug circulation link.
3. The system according to claim 2, wherein the drug tracing code information includes a unique tracing back identifier of the drug minimum sales unit and an identifier association relationship between the unique tracing back identifiers set on the respective levels of the outer packages of the drug minimum sales unit.
4. The system of claim 2, wherein the drug data collection unit is specifically configured to:
when the drug production link of the drug minimum sale unit is detected to be ex-warehouse, the out-warehouse receipt information and the drug tracing code information of the drug minimum sale unit in the drug production link are collected to be used as drug tracing data when the drugs of the drug minimum sale unit are circulated in the drug production link.
5. The system of claim 2, wherein the drug data collection unit is specifically configured to:
when detecting that the minimum medicine sales unit is put in storage in the medicine circulation link, carrying out consistency verification on corresponding tracing code information and ex-storage document information provided in the medicine production link and corresponding ex-storage document information collected in the medicine production link;
and under the condition of passing the verification, acquiring the delivery receipt and the drug tracing code information of the drug minimum sale unit in the drug circulation link, so as to be used as drug tracing data of the drug minimum sale unit when the drug is circulated in the drug circulation link.
6. The system of claim 2, wherein the drug data collection unit is specifically configured to:
when the minimum medicine sales unit is detected to be put in storage in the medicine sales link, consistency verification is carried out on corresponding tracing code information and ex-storage document information provided in the medicine circulation link and corresponding ex-storage document information collected in the medicine circulation link;
and under the condition of passing the verification, acquiring the ex-warehouse receipt and the medicine tracing code information of the minimum medicine selling unit in the medicine selling link to serve as medicine tracing data of the minimum medicine selling unit when the medicine is circulated in the medicine selling link.
7. The system according to claim 1, wherein the drug data collection unit is connected to scanning devices arranged in different circulation links, and the scanning devices are configured to scan and obtain the tracing code information of the drug minimum sales unit to obtain the drug tracing data.
8. The system of claim 1, wherein the drug data collection unit is connected to a third party data platform for providing drug traceability data for at least part of the diversion links for the drug min-selling unit.
9. The system of claim 1, wherein the drug data storage unit is specifically configured to:
and adopting a block chain technology to carry out uplink storage on the medicine tracing data of the minimum medicine sale unit in each medicine circulation link, and integrating the uplink stored medicine tracing data of each minimum medicine sale unit which belongs to the same medicine.
10. The system of claim 1, wherein the drug data analysis unit is specifically configured to:
when a consumer scans a minimum drug sale unit, drug tracing data related to the scanned minimum drug sale unit is inquired;
and determining whether the current medicine flow direction of the scanned medicine minimum selling unit is consistent with the medicine flow direction indicated by the pre-stored medicine tracing data or not, so as to determine whether to trigger the early warning of the serial goods of the scanned medicine minimum selling unit or not.
11. The system of claim 1, wherein the drug data analysis unit is specifically configured to:
and analyzing the medicine flow direction distribution of the similar medicines based on the medicine tracing data associated with the minimum medicine sale units to obtain the inventory distribution and warehouse-in and warehouse-out distribution conditions of the similar medicines in different jurisdictions.
12. The system of claim 1, wherein the drug data analysis unit is specifically configured to:
according to preset medicine early warning rules, early warning analysis is carried out on each medicine minimum sale unit, so that medicine recalling is carried out on the medicine minimum sale units which accord with the early warning rules;
wherein the early warning rules include at least one of: production license expiration warning, GMP certificate expiration warning, operation license certificate expiration warning, GSP certificate expiration warning, approved document number expiration warning and drug expiration warning.
13. A method for monitoring and warning drugs, the method comprising:
collecting drug tracing data reported by a drug minimum sale unit when each drug circulation link carries out circulation; wherein, the medicine circulation link comprises: a drug production link, a drug circulation link and a drug sales link;
linking and storing the drug tracing data of the drug minimum sale unit in each drug circulation link;
and carrying out early warning analysis on the minimum medicine sale unit according to the medicine tracing data associated with the minimum medicine sale unit.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010995358.8A CN112184259A (en) | 2020-09-21 | 2020-09-21 | Drug supervision early warning system and method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010995358.8A CN112184259A (en) | 2020-09-21 | 2020-09-21 | Drug supervision early warning system and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112184259A true CN112184259A (en) | 2021-01-05 |
Family
ID=73955690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010995358.8A Pending CN112184259A (en) | 2020-09-21 | 2020-09-21 | Drug supervision early warning system and method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112184259A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116308042A (en) * | 2023-03-06 | 2023-06-23 | 苏州永固智能科技有限公司 | Intelligent treatment cabinet-based whole-course traceable management system for high-risk medicines |
| CN117408613A (en) * | 2023-12-14 | 2024-01-16 | 广东鑫港湾供应链管理有限公司 | Quick drug delivery package delivery method |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103198409A (en) * | 2013-03-28 | 2013-07-10 | 福州天虹电脑科技有限公司 | Off-site regulation method used for medicine circulation |
| CN104021459A (en) * | 2014-06-27 | 2014-09-03 | 漳州片仔癀药业股份有限公司 | Method for realizing pharmaceutical production supervision on basis of supervision code and traceability code |
| CN104574242A (en) * | 2013-10-28 | 2015-04-29 | 吴洪贵 | Intelligent drug tracing system |
| CN106384242A (en) * | 2016-09-05 | 2017-02-08 | 广州中国科学院软件应用技术研究所 | Tracking code repetition early warning system based on food safety |
| CN109993546A (en) * | 2019-02-18 | 2019-07-09 | 西安西电链融科技有限公司 | A kind of drug traceability system and implementation method based on RFID and block chain |
| CN111401809A (en) * | 2020-03-17 | 2020-07-10 | 中追(广东)信息科技有限公司 | Product quality safety block chain traceability system |
-
2020
- 2020-09-21 CN CN202010995358.8A patent/CN112184259A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103198409A (en) * | 2013-03-28 | 2013-07-10 | 福州天虹电脑科技有限公司 | Off-site regulation method used for medicine circulation |
| CN104574242A (en) * | 2013-10-28 | 2015-04-29 | 吴洪贵 | Intelligent drug tracing system |
| CN104021459A (en) * | 2014-06-27 | 2014-09-03 | 漳州片仔癀药业股份有限公司 | Method for realizing pharmaceutical production supervision on basis of supervision code and traceability code |
| CN106384242A (en) * | 2016-09-05 | 2017-02-08 | 广州中国科学院软件应用技术研究所 | Tracking code repetition early warning system based on food safety |
| CN109993546A (en) * | 2019-02-18 | 2019-07-09 | 西安西电链融科技有限公司 | A kind of drug traceability system and implementation method based on RFID and block chain |
| CN111401809A (en) * | 2020-03-17 | 2020-07-10 | 中追(广东)信息科技有限公司 | Product quality safety block chain traceability system |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116308042A (en) * | 2023-03-06 | 2023-06-23 | 苏州永固智能科技有限公司 | Intelligent treatment cabinet-based whole-course traceable management system for high-risk medicines |
| CN117408613A (en) * | 2023-12-14 | 2024-01-16 | 广东鑫港湾供应链管理有限公司 | Quick drug delivery package delivery method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kshetri et al. | Blockchain adoption in supply chain networks in Asia | |
| US7156305B2 (en) | Apparatus and method for authenticating products | |
| RU2639015C1 (en) | Authenticity and quality control procedure of production in the process of manufacture and implementation | |
| CN109478305A (en) | Information system for item authentication | |
| Rotunno et al. | Impact of track and trace integration on pharmaceutical production systems | |
| CN106296228A (en) | A kind of product product control source tracing method | |
| CN101556667A (en) | Database-monitoring system and data-processing method thereof used for food safety traceability | |
| CN112184259A (en) | Drug supervision early warning system and method | |
| WO2020198333A1 (en) | Product labels, trust identifier systems containing the same, and methods of use thereof | |
| CN114819862A (en) | Cold-chain logistics tracing service method, system and storage medium | |
| CN105868977A (en) | Drug sale supervision method, system and apparatus | |
| CN107103481A (en) | Equipment based on sequence number information processing system after sale | |
| CN110599197A (en) | Electronic tracing system and method for food safety production | |
| Qiao et al. | Research on vegetable supply chain traceability model based on two-dimensional barcode | |
| Zhang et al. | A blockchain-enabled framework for reverse supply chain management of power batteries | |
| CN114529312A (en) | Traceability management system | |
| Gartner et al. | Potentials of traceability systems-a cross-industry perspective | |
| CN106335704A (en) | Intelligent packaging box supporting online payment and realization method for intelligent packaging box | |
| CN102855513B (en) | A kind of false proof and quality data code generating means and its system | |
| JP2003345413A (en) | Process information management system | |
| CN110097378B (en) | Commodity transaction recording and circulation incentive method based on block chain technology | |
| CN112288451A (en) | Food quality safety tracing system and tracing method | |
| US20230065582A1 (en) | System and method for healthcare raw material secure serialization and validation | |
| CN109063800A (en) | One one yard of object control valence management system and method | |
| CN114897537A (en) | Fermented vegetable tracing system based on block chain technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |